U.S. MarketsAugust 18 at 05:33 AM

FDA is considering a competency-based approach to evaluating generative AI-enabled medical devices, similar to assessments for doctors, according to Axios.

StockNow breaking-news AI analysis

The FDA is considering assessing generative AI devices based on competency, mirroring doctor evaluations, amid a medical AI market projected to grow over 35% annually through 2035.

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

Other

Taiwan power semiconductor manufacturers are reportedly looking to raise prices, targeting non-contract products by 10-15%; could be done by October

Geopolitics

Iranian Parliamentary Speaker Ghalibaf says the Strait of Hormuz will not open until the blockade and oil embargo are lifted. Adds, "Iran is ready to inflict a heavier defeat on the enemy than before, in proportion to his actions and encroachments."

Politics